13605-21-5Relevant articles and documents
HISTONE DEMETHYLASE INHIBITORS
-
Paragraph 00116; 00117, (2017/09/08)
This disclosure relates to compounds that inhibit histone demethylase activity. In particular, the disclosure relates to compounds that inhibit histone lysine demethylase KDM5B, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions disclosed herein.